| | | | | | | | |
(In thousands) | | | 2023 | | | | 2022 | |
CASH FLOWS FROM OPERATING ACTIVITIES: | | | | | | | | |
Net earnings | | $ | 514,457 | | | $ | 704,964 | |
Adjustments to reconcile net earnings to net cash used in operating activities: | | | | | | | | |
| | | | | | | | |
Depreciation | | | 110,563 | | | | 94,063 | |
Amortization of intangibles | | | 21,327 | | | | 19,499 | |
Expense associated with share-based and grant compensation arrangements | | | 34,899 | | | | 28,156 | |
Deferred income taxes (credit) | | | (5,573) | | | | (16,289) | |
Unrealized (gain) loss on investment and other | | | (2,435) | | | | 5,768 | |
Equity in loss of investee | | | 2,367 | | | | 2,183 | |
Net (gain) loss on sale and disposition of assets | | | (260) | | | | 1,285 | |
Impairment of goodwill and other intangibles | | | — | | | | 4,261 | |
Gain from reduction of estimated earnout liability | | | (3,177) | | | | — | |
Changes in: | | | | | | | | |
Accounts receivable | | | 81,659 | | | | 130,704 | |
Inventories | | | 250,561 | | | | 718 | |
Accounts payable and cash overdraft | | | (3,578) | | | | (137,907) | |
Accrued liabilities and other | | | (40,920) | | | | (5,838) | |
NET CASH FROM OPERATING ACTIVITIES | | | 959,890 | | | | 831,567 | |
| | | | | | | | |
CASH FLOWS USED IN INVESTING ACTIVITIES: | | | | | | | | |
Purchases of property, plant, and equipment | | | (180,382) | | | | (174,124) | |
Proceeds from sale of property, plant and equipment | | | 3,291 | | | | 3,805 | |
Acquisitions, net of cash received and purchase of equity method investment | | | (52,383) | | | | (180,151) | |
Purchase of remaining noncontrolling interest of subsidiary | | | (2,127) | | | | — | |
Purchases of investments | | | (29,806) | | | | (19,875) | |
Proceeds from sale of investments | | | 29,935 | | | | 12,874 | |
Other | | | (8,692) | | | | 3,535 | |
NET CASH USED IN INVESTING ACTIVITIES | | | (240,164) | | | | (353,936) | |
| | | | | | | | |
CASH FLOWS USED IN FINANCING ACTIVITIES: | | | | | | | | |
Borrowings under revolving credit facilities | | | 28,462 | | | | 605,101 | |
Repayments under revolving credit facilities | | | (30,125) | | | | (607,549) | |
Repayments of debt | | | (29) | | | | (38,719) | |
Contingent consideration payments and other | | | (6,262) | | | | (2,856) | |
Proceeds from issuance of common stock | | | 2,750 | | | | 2,769 | |
Dividends paid to shareholders | | | (68,238) | | | | (58,860) | |
Distributions to noncontrolling interest | | | (7,355) | | | | (12,024) | |
Repurchase of common stock | | | (82,149) | | | | (95,774) | |
Other | | | 86 | | | | (2,298) | |
NET CASH USED IN FINANCING ACTIVITIES | | | (162,860) | | | | (210,210) | |
| | | | | | | | |
Effect of exchange rate changes on cash | | | 5,767 | | | | 979 | |
NET CHANGE IN CASH AND CASH EQUIVALENTS | | | 562,633 | | | | 268,400 | |
| | | | | | | | |
ALL CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD | | | 559,623 | | | | 291,223 | |
| | | | | | | | |
ALL CASH AND CASH EQUIVALENTS, END OF PERIOD | | $ | 1,122,256 | | | $ | 559,623 | |
| | | | | | | | |
Reconciliation of cash and cash equivalents and restricted cash: | | | | | | | | |
Cash and cash equivalents, beginning of period | | $ | 559,397 | | | $ | 286,662 | |
Restricted cash, beginning of period | | | 226 | | | | 4,561 | |
All cash and cash equivalents, beginning of period | | $ | 559,623 | | | $ | 291,223 | |
| | | | | | | | |
Cash and cash equivalents, end of period | | $ | 1,118,329 | | | $ | 559,397 | |
Restricted cash, end of period | | | 3,927 | | | | 226 | |
All cash and cash equivalents, end of period | | $ | 1,122,256 | | | $ | 559,623 | |
| | | | | | | | |